NAMSDL is a 501(c)(3) nonprofit organization dedicated to comprehensive, integrative and effective state drug laws, policies and programs
Highlighted Issues

As part of the Novel Psychoactive Substances (NPS) Model Law Package, this updated law improves on current laws by clarifying the “analogue” definition and highlighting factors that indicate an emerging substance should be treated as one. Read more »

analog analogue fentanyl model act model law new psychoactive substance novel psychoactive substance NPS synthetic drug


This document provides a summary of legislation and regulation introduced during calendar year 2017 that pertains to novel psychoactive substances (“NPS”) and controlled substance analogues. Read more »

analog analogue bill status update cannabinoid cathinone designer drug fentanyl new psychoactive substance novel psychoactive substance nps schedule synthetic drug